FDA approves Vivus' avanafil for erectile dysfunction

04/28/2012 | MedPage Today (free registration)

Vivus' avanafil, a PDE-5 inhibitor, received FDA approval for erectile dysfunction. Dr. Victoria Kusiak of the FDA Center for Drug Evaluation and Research said the "approval expands the available treatment options to men experiencing erectile dysfunction and enables patients ... to choose the most appropriate treatment for their needs."

View Full Article in:

MedPage Today (free registration)

Published in Briefs: